Drugmakers' payments to FDA for reviews to increase by 29%

chicagotribune.com — WASHINGTON -- Drugmakers have agreed to a nearly 29 percent increase in payments to federal regulators to ensure speedy approvals of new medicines and step up safety monitoring, a person familiar with the deal said Tuesday. Representatives of drugmakers and their trade associations also agreed for the first time to pay fees to have ... Nov 22, 2006 View in Crawl 4